Science 37 Holdings, Inc.
NASDAQ:SNCE
5.75 (USD) • At close March 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 14.887 | 15.351 | 14.086 | 15.936 | 16.249 | 19.275 | 18.686 | 20.376 | 0 | 12.438 | 0 | 0 |
| Cost of Revenue
| 8.972 | 9.964 | 11.11 | 12.293 | 12.157 | 13.842 | 15.986 | 16.148 | 0.831 | 8.638 | 0 | 0 |
| Gross Profit
| 5.915 | 5.387 | 2.976 | 3.643 | 4.092 | 5.433 | 2.7 | 4.228 | -0.831 | 3.8 | 0 | 0 |
| Gross Profit Ratio
| 0.397 | 0.351 | 0.211 | 0.229 | 0.252 | 0.282 | 0.144 | 0.207 | 0 | 0.306 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0.831 | 0.831 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 14.74 | 0 | 0 | 0 | 0 | 0 | 0 | 34.815 | 0 | 0 | 0 | 0 |
| SG&A
| 14.742 | 16.593 | 20.481 | 20.432 | 24.485 | 28.183 | 30.153 | 35.646 | 0.831 | 9.164 | 0 | 0 |
| Other Expenses
| -0.109 | 0.009 | 0.213 | 5.373 | 4.87 | 4.23 | 3.469 | 0.229 | 0 | 0.034 | -0.081 | 0 |
| Operating Expenses
| 14.906 | 16.736 | 20.694 | 25.805 | 29.355 | 32.413 | 33.622 | 38.256 | 0.831 | 10.661 | -0.081 | 0 |
| Operating Income
| -14.544 | -20.401 | -17.718 | 23.415 | -25.263 | -26.98 | -30.922 | -34.028 | -0.831 | -6.861 | -0.081 | -0 |
| Operating Income Ratio
| -0.977 | -1.329 | -1.258 | 1.469 | -1.555 | -1.4 | -1.655 | -1.67 | 0 | -0.552 | 0 | 0 |
| Total Other Income Expenses Net
| -5.664 | -9.043 | -6.91 | -90.024 | 1.735 | 21.147 | 75.815 | -31.071 | 0.001 | 0.034 | 0 | 0 |
| Income Before Tax
| -13.923 | -19.579 | -24.628 | -66.609 | -23.528 | -5.833 | 44.893 | -65.098 | -0.83 | -6.826 | -0.081 | -0 |
| Income Before Tax Ratio
| -0.935 | -1.275 | -1.748 | -4.18 | -1.448 | -0.303 | 2.402 | -3.195 | 0 | -0.549 | 0 | 0 |
| Income Tax Expense
| 0.001 | 8.239 | -1.12 | -0.088 | -3.494 | -42.142 | -0.001 | 0.001 | -0.001 | -0.036 | 0 | 0 |
| Net Income
| -13.924 | -19.579 | -23.508 | -66.521 | -20.034 | 36.309 | 44.894 | -65.099 | -0.83 | -6.826 | -0.081 | -0 |
| Net Income Ratio
| -0.935 | -1.275 | -1.669 | -4.174 | -1.233 | 1.884 | 2.403 | -3.195 | 0 | -0.549 | 0 | 0 |
| EPS
| -0.12 | -0.17 | -0.2 | -0.57 | -0.17 | 0.31 | 0.35 | -0.6 | -0.007 | -0.06 | -0.01 | 0 |
| EPS Diluted
| -0.12 | -0.17 | -0.2 | -0.57 | -0.17 | 0.31 | 0.35 | -0.6 | -0.007 | -0.06 | -0.043 | 0 |
| EBITDA
| -3.272 | -2.153 | -9.585 | 28.788 | -21.593 | -43.65 | -102.953 | -0.118 | -0.831 | -5.364 | -0.081 | -0 |
| EBITDA Ratio
| -0.22 | -0.14 | -0.68 | 1.806 | -1.329 | -2.265 | -5.51 | -0.006 | 0 | -0.431 | 0 | 0 |